Ksenia Maslenkina

Ms. Ksenia Maslenkina

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
NSNikolay K Shakhpazyan
Nikolay K Shakhpazyan
LMLiudmila Mikhaleva
Liudmila Mikhaleva
ABArkady Bedzhanyan
Arkady Bedzhanyan
НСНиколай Садыхов
Николай Садыхов
KMKonstantin Midiber
Konstantin Midiber
Alexander N. OrekhovAlexander N. Orekhov
Alexander N. Orekhov
This comprehensive review elucidates the intricate roles of long non-coding RNAs (lncRNAs) within the colorectal cancer (CRC) microenvironment, intersecting the domains of immunity, intercellular communication, and therapeutic potential. lncRNAs, which are significantly involved in the pathogenesis of CRC, immune evasion, and the treatment response to CRC, have crucial implications in inflammation and serve as promising candidates for novel therapeutic strategies and biomarkers. This review scrutinizes the interaction of lncRNAs with the Consensus Molecular Subtypes (CMSs) of CRC, their complex interplay with the tumor stroma affecting immunity and inflammation, and their conveyance via extracellular vesicles, particularly exosomes. Furthermore, we delve into the intricate relationship between lncRNAs and other non-coding RNAs, including microRNAs and circular RNAs, in mediating cell-to-cell communication within the CRC microenvironment. Lastly, we propose potential strategies to manipulate lncRNAs to enhance anti-tumor immunity, thereby underlining the significance of lncRNAs in devising innovative therapeutic interventions in CRC.

6 December 2021 in Cancer Medicine
Verified
Journal Article
Open access
PDF file
KMKsenia Maslenkina
Ksenia Maslenkina
AKAlexandra K. Konyukova
Alexandra K. Konyukova
DADarya Y. Alexeeva
Darya Y. Alexeeva
MSMikhail Sinelnikov
Mikhail Sinelnikov
LMLiudmila M. Mikhaleva
Liudmila M. Mikhaleva
Barrett's esophagus is a widespread chronically progressing disease of heterogeneous nature. A life threatening complication of this condition is neoplastic transformation, which is often overlooked due to lack of standardized approaches in diagnosis, preventative measures and treatment. In this essay, we aim to stratify existing data to show specific associations between neoplastic transformation and the underlying processes which predate cancerous transition. We discuss pathomorphological, genetic, epigenetic, molecular and immunohistochemical methods related to neoplasia detection on the basis of Barrett's esophagus. Our review sheds light on pathways of such neoplastic progression in the distal esophagus, providing valuable insight into progression assessment, preventative targets and treatment modalities. Our results suggest that molecular, genetic and epigenetic alterations in the esophagus arise earlier than cancerous transformation, meaning the discussed targets can help form preventative strategies in at‐risk patient groups.

Verified
Journal Article
Open access
PDF file
KMKsenia Maslenkina
Ksenia Maslenkina
LMLiudmila Mikhaleva
Liudmila Mikhaleva
MNMaxim Naumenko
Maxim Naumenko
RVRositsa Vandysheva
Rositsa Vandysheva
MGMikhail Yurevich Gushchin
Mikhail Yurevich Gushchin
MTMarkus Tiemann
Markus Tiemann
Barrett’s esophagus (BE) is a premalignant lesion that can develop into esophageal adenocarcinoma (EAC). The development of Barrett’s esophagus is caused by biliary reflux, which causes extensive mutagenesis in the stem cells of the epithelium in the distal esophagus and gastro-esophageal junction. Other possible cellular origins of BE include the stem cells of the mucosal esophageal glands and their ducts, the stem cells of the stomach, residual embryonic cells and circulating bone marrow stem cells. The classical concept of healing a caustic lesion has been replaced by the concept of a cytokine storm, which forms an inflammatory microenvironment eliciting a phenotypic shift toward intestinal metaplasia of the distal esophagus. This review describes the roles of the NOTCH, hedgehog, NF-κB and IL6/STAT3 molecular pathways in the pathogenesis of BE and EAC.

26 April 2023 in Preprints.org
Verified
Preprint
Open access
KMKsenia Maslenkina
Ksenia Maslenkina
LMLiudmila Mikhaleva
Liudmila Mikhaleva
MNMaxim Naumenko
Maxim Naumenko
RVRositsa Vandysheva
Rositsa Vandysheva
MGMichail Gushchin
Michail Gushchin
MTMarkus Tiemann
Markus Tiemann
Barrett’s esophagus (BE) is a premalignant lesion for esophageal adenocarcinoma (EAC). Development of Barrett’s esophagus is caused by biliary reflux that provokes intensive mutagenesis in stem cells of epithelium in distal esophagus and gastro-esophageal junction. Other possible cell origins of Barrett’s esophagus include stem cells of mucosal esophageal glands and their ducts, of stomach, residual embryonic cells and circulating bone marrow stem cells. Classic conception of healing of caustic lesion was replaced by idea of cytokine storm that forms inflammatory microenvironment for phenotypic shift toward intestinal metaplasia of distal esophagus. The review summarizes contemporary concepts of BE and EAC pathogenesis.

6 February 2024 in Russian Journal of Archive of Pathology
Verified
Journal Article
Closed access
KMKsenia Maslenkina
Ksenia Maslenkina
EME.N. Motylev
E.N. Motylev
MGM.YU. Guschin
M.YU. Guschin
RVR.A. Vandysheva
R.A. Vandysheva
LMLiudmila Mikhaleva
Liudmila Mikhaleva
BACKGROUND Eosinophilic esophagitis (EoE) is an immune-mediated disease, manifested by dysphagia and characterized by intraepithelial infiltration: more than 15 eosinophils per field of view at x400 magnification, and requiring differential diagnosis with reflux esophagitis (RE). OBJECTIVE To access the implication of EoE histologic scoring system (EoEHSS) for differential diagnosis of EoE and RE and to characterize features of immune response in these diseases. MATERIAL AND METHODS 38 patients with EoE and 38 patients with RE were enrolled in the study. All the patients had esophagogastroduodenoscopy with biopsy. Biopsy specimens were stained with H&E and combined PAS/Alcian blue staining. Immunohistochemical evaluation was conducted with antibodies to CD3, CD4, CD8, CD20, CD56 and CD68. RESULTS Grade score of EoEHSS in EoE was 2.4 times more than in RE (p<0.05). Stage score in EoE was 2.75 more than in RE (p<0.05). Intraepithelial count of CD3+ T-lymphocytes comprised 87 (76—95.5) in high-power view in EoE and 45 (38.5—48.5) in high-power view in RE. Intraepithelial count of CD4+ T-lymphocytes was 35 (28—41.5) in high-power view in EoE and 19 (16.5— 22.5) in high-power view in RE. Intraepithelial count of CD8+ T-lymphocytes comprised 59 (50.5—67.5) in high-power field in EoE and 27 (24—28.5) in high-power field in RE. CONCLUSION The use of the EoEHSS histological rating scale for eosinophilic esophagitis is effective in the differential diagnosis of EoE and EC. Predominant cells in intraepithelial infiltrate are CD3+ T-lymphocytes both in EoE and RE, CD8+ cells prevail over CD4+ cells. In EoE intraepithelial count of CD3+ T-lymphocytes is 1.93 times more, count of intraepithelial CD4+ lymphocytes is 1.84 times more and count of CD8+ lymphocytes is 2.19 times more than in RE.

1 January 2023 in CLINICAL AND EXPERIMENTAL MORPHOLOGY
Verified
Journal Article
Closed access
KMKsenia Maslenkina
Ksenia Maslenkina
LMLiudmila Mikhaleva
Liudmila Mikhaleva
EME.N. Motylev
E.N. Motylev
MGMikhail Yurevich Gushchin
Mikhail Yurevich Gushchin
VKV.O. Kaibysheva Kaibysheva
V.O. Kaibysheva Kaibysheva
GKG.Y. Kudryavtsev
G.Y. Kudryavtsev
Eosinophilic esophagitis (EoE) is an immune-mediated disease that presents with dysphagia and esophageal bolus obstruction and is characterized by predominant intraepithelial eosinophilic infiltration at histology. The aim of our literature review was to delineate clinical and morphological EoE features in terms of differential diagnosis with other esophageal diseases, i.e., gastroesophageal reflux disease (GERD), inflammatory bowel diseases (IBDs), autoimmune diseases, and rare esophageal disorders. Clinical features of dysphagia and esophageal bolus obstruction and endoscopic criteria (according to EREFS) are typical of EoE. Nevertheless, eosinophilia of the esophageal mucosa is not a specific marker of mucosal injury and is not sufficient for EoE diagnosis. Therefore, eosinophilic esophagitis histological scoring system (EoEHSS) was developed. It involves assessment of intraepithelial eosinophilic infiltration, basal zone hyperplasia, eosinophilic abscesses, eosinophil surface layering, dilated intercellular spaces, surface epithelial alteration, dyskeratotic epithelial cells, and lamina propria fibrosis. Complex clinical, endoscopic, and histological evaluation allows accurate diagnosis of EoE and other causal factors of esophageal eosinophilia. Keywords: eosinophilic esophagitis, esophageal eosinophilia, gastroesophageal reflux disease, celiac disease, inflammatory bowel diseases, achalasia, atopy